Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Capital Employed (ROCE) | 9.2% | 14.4% | 10.6% | 11.5% | 13.9% | 14.6% | 13.4% | 9.6% | 11.0% | 10.9% | 9.6% | 11.9% | 12.9% | 3.4% | 14.7% | 16.8% | 10.0% | 10.4% | 9.2% | 10.5% |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Microsoft Corp's last 12-month Return on Capital Employed (ROCE) is 8.1%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Return on Capital Employed (ROCE) for Amgen Inc. have been 11.9% over the past three years, and 13.9% over the past five years.
As of today, Amgen Inc.'s Return on Capital Employed (ROCE) is 8.1%, which is lower than industry median of 12.8%. It indicates that Amgen Inc.'s Return on Capital Employed (ROCE) is Bad.